Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients

Journal of the American Society of Nephrology

Volumn 13, Issue 5, 2002, Pages 1321-1330

  Tarng, Der Cherng ^a   Chen, Tzen Wen ^a   Huang, Tung Po ^a   Chen, Chiu Lan ^a   Liu, Tsung Yun ^a   Wei, Yau Huei ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLESTEROL; DNA; FERRITIN; GLUTATHIONE; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; TRANSFERRIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHRONIC KIDNEY FAILURE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE CLEARANCE; DISEASE COURSE; ELECTROCHEMICAL ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; FLOW CYTOMETRY; GRANULOCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEUKOCYTE; MALE; MEASUREMENT; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; STANDARDIZATION; TRANSFERRIN BLOOD LEVEL;

EID: 0036236428     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000013301.11876.7E     Document Type: Article

References (52)

1. The effect of dialysate on peritoneal phagocyte oxidative metabolism
2. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression
3. Biocompatibility of peritoneal dialysis solutions
4. The effect of peritoneal dialysis fluid on the release of IL-lβ and TNFα by macrophages/monocytes
5. Free radicals in peritoneal dialysis: Agents of damage?
6. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients
7. Elevation of whole-blood glutathione in peritoneal dialysis patients by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug (procysteine)
8. Effect of peritoneal dialysis on plasma levels of ascorbic acid
9. Ascorbic acid supplements in patients receiving chronic peritoneal dialysis
10. Effect of dialysis on oxidative stress in uraemia
11. Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients
12. Antioxidant enzymes activity in polymorphonuclear leukocytes in chronic renal failure
13. Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis patients
14. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy
15. Endogenous oxidative DNA damage, aging, and cancer
16. Localization of strand breaks in plasmid DNA treated with reactive oxygen species
17. Oxidative decay of DNA
18. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis
19. 8-Hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients
20. Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients
21. Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients
22. Lipid peroxidation and antioxidant enzymes in CAPD patients
23. Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds
24. Advanced oxidation protein products as a novel marker of oxidative stress in uremia
25. 2, vitamin C and calcium
26. Composition of foods used in Taiwan supplements
27. Improved method for the determination of blood glutathione
28. Determination of oxidized glutathione in blood: High-performance liquid chromatography
29. A simple colorimetric method for ascorbic acid determination in blood plasma
30. Simultaneous determination of retinol and α-tocopherol in serum or plasma by liquid chromatography
31. Isolation of DNA from blood
32. Assays of oxidative DNA damage biomarkers 8-oxa-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection
33. Oxidative product formation analysis by flow cytometry
34. Intradialytic granulocyte reactive oxygen species production: A prospective, crossover trial
35. Effect of high glucose on peritoneal mesothelial cell biology
36. Serum and erythrocyte tocopherol in uremic patients: Effect of hemodialysis versus peritoneal dialysis
37. Adipose tissue fatty acid composition, serum lipid, and serum α-tocopherol in continuous ambulatory peritoneal dialysis patients living on the island of Crete
38. Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter
39. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease
40. Oxidative stress and antioxidant status in β-thalassemia major: Iron overload and depletion of lipid-soluble antioxidants
41. The presence and toxicity of guanidinopropronic acid in uremia
42. Serum factor from patients with chronic renal failure enhances polymorphonuclear leukocyte oxidative metabolism
43. Chemiluminescence detection of polymorphonuclear leukocyte stimulating factor in patients with chronic renal failure before and after transplantation
44. Relationship between the intracellular reactive oxygen species and the induction of oxidative DNA damage in human neutrophil-like cells
45. Oxidative damage to DNA constituents by iron-mediated Fenton reactions
46. Oxidative damage to DNA constituents by iron-mediated fenton reactions
47. Oxidative DNA damage, antioxidants, and cancer
48. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation
49. Prospective aspects for atherogenesis and lipid abnormalities in continuous ambulatory peritoneal dialysis patients
50. 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum
51. Cancer among patients on renal replacement therapy: A population-based survey in Lombardy, Italy
52. Biocompatible of new peritoneal dialysis solutions: Clinical experience